Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2034
Description
Anastomosis Devices Market Summary
This Anastomosis devices market report offers a comprehensive overview of the global Anastomosis devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product (Surgical Staplers {Powered, Manual}, Surgical Sutures, Surgical Sealant, Surgical Adhesives, and Others), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, General Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing anastomosis devices market.
Anastomosis devices are medical instruments designed to surgically connect two hollow structures, such as blood vessels or segments of the intestine. They enable surgeons to create secure and precise connections during procedures including gastrointestinal, cardiovascular, and colorectal surgeries.
The overall anastomosis devices market is being collectively boosted by several converging factors, including the rising volume of surgical procedures and the growing burden of chronic diseases such as cardiovascular disorders, cancer, and gastrointestinal conditions which often require surgical resection and reconnection of tissues. Additionally, increased adoption of minimally invasive and robotic-assisted surgeries are driving demand for advanced anastomosis devices that offer precision and faster recovery. Furthermore, continuous product development and technological advancements are improving device safety, ease of use, and clinical outcomes, encouraging wider adoption among surgeons. Favorable healthcare infrastructure, improved reimbursement in developed regions, and increasing awareness about the benefits of automated and stapling-based anastomosis techniques are further supporting market growth. Together, these factors are accelerating adoption across hospitals, clinics, and ambulatory surgical centers, fueling robust growth in the anastomosis devices market.
Get More Insights into the Report @Anastomosis Devices Market
What are the latest anastomosis devices market dynamics and trends?
The global market for anastomosis devices has witnessed significant growth in recent years, largely driven by increasing demand for surgical procedures due to the expanding burden of chronic illnesses such as cardiovascular diseases and gastrointestinal diseases.
Impact of Cardiovascular Diseases:
According to the National Library of Medicine (2025), the global burden of peripheral artery disease (PAD) is rising sharply, with an estimated 113 million people affected in 2021, a number projected to increase to 189 million by 2030, 273 million by 2040, and 363 million by 2050. PAD is characterized by progressive arterial narrowing and blockage, often in the lower limbs, which frequently necessitates bypass surgeries, endarterectomy, and revascularization procedures when medical therapy or angioplasty is insufficient. These procedures rely heavily on vascular anastomosis devices such as coupling systems, proximal anastomosis devices, and suturing or stapling tools to restore blood flow efficiently and safely.
Impact of Gastrointestinal Diseases
According to the International Agency for Research on Cancer (2025), approximately 2.06 million new cases of colorectal cancer were reported worldwide in 2025, and this number is projected to rise to around 3.29 million by 2045. The growth of colorectal cancer cases is mainly because its treatment often requires surgical intervention. Surgery is a primary approach for managing colorectal cancer and typically involves removing the affected section of the bowel and reconnecting the remaining parts using anastomosis devices such as staplers and sutures.
However, the increasing product development activities auch as approvals, new product launches among the key market players are further escalating the market.For Example, in September 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration had cleared its MagDIâ„¢ System for side-to-side duodeno-ileal (DI) anastomosis, marking a significant milestone in the use of innovative magnetic compression technology for digestive surgery.
However, one of the major challenges in the anastomosis devices market is the risk of anastomotic leakage and other post-operative complications. Anastomotic leakage occurs when the surgical connection between two hollow structures, such as blood vessels or intestinal segments, fails to seal properly, allowing fluids or contents to escape. This can lead to serious complications, including infection, prolonged hospital stays, additional surgeries, and even life-threatening conditions. Because of this risk, surgeons may be cautious in adopting new or advanced anastomosis devices, especially if clinical evidence supporting their safety and reliability is limited. As a result, device manufacturers must focus on improving precision, durability, and safety features to reduce leakage rates, which directly influences the market adoption and growth of anastomosis devices.
Anastomosis Devices Market Segment Analysis
Anastomosis Devices Market by Product (Surgical Staplers {Powered, Manual}, Surgical Sutures, Surgical Sealant, Surgical Adhesives, and Others), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, General Surgery, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Anastomosis Devices Market Regional Analysis
North America Anastomosis Devices Market Trends
North America is expected to account for the highest proportion of 42% of the anastomosis devices market in 2025, out of all regions. North America is expected to dominate the overall anastomosis devices market due to its well-established healthcare infrastructure, high surgical procedure volumes, and early adoption of advanced surgical technologies. The region has a strong presence of leading medical device manufacturers and continuous investment in research and product innovation, which accelerates the availability of technologically advanced anastomosis devices.
According to the Centers for Disease Control and Prevention (2024), approximately 6.5 million people aged 40 years and older in the United States were living with peripheral artery disease (PAD). This high prevalence of PAD significantly boosted the anastomosis devices market, as many patients required vascular interventions such as bypass and revascularization surgeries to restore blood flow. These procedures rely heavily on precise and secure vessel connections, increasing the demand for advanced anastomosis devices that improve surgical efficiency, reduce complications, and support better patient outcomes.
Additionally, according to the Centers for Disease Control and Prevention (2024), the prevalence of inflammatory bowel disease (IBD) in the United States was estimated to be between 2.4 and 3.1 million people, with up to 3.1 million adults affected based on national survey data. This substantial patient population has contributed to the growth of the anastomosis devices market, as a significant number of IBD patients require surgical intervention when medical therapies are no longer effective. Surgical treatment for conditions such as Crohn’s disease and ulcerative colitis often involves removing diseased sections of the intestine and reconnecting healthy bowel segments, a procedure that relies on anastomosis devices. As the incidence of IBD increased, the demand for safe, reliable, and efficient anastomosis devices used in gastrointestinal surgeries also rose, thereby supporting overall market expansion.
However, the increasing product development activities among the key market players are further escalating the market. For instance, in August 2025, Phraxis, Inc., a leader in vascular access innovation, announced the successful completion of the first commercial case using its EndoForceâ„¢ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.
Therefore, the above-mentioned factors are expected to bloster the growth of the anastomosis devices market in North America during the forecast period.
Europe Anastomosis Devices Market Trends
In Europe, the groth of anastomosis devices market is driven by a high prevalence of chronic diseases, and rising demand for complex surgeries. Strong healthcare infrastructure, early adoption of advanced, minimally invasive, and robotic-assisted surgical technologies further drive market growth and adoption across hospitals and surgical centers.
According to the International Agency for Research on Cancer (2025), around 552,000 new colorectum cancer cases were reported in 2025, and this number is expected to rise to approximately 682,000 by 2045.The rising number of cancer cases, especially colorectal and gastrointestinal cancers, is driving demand for anastomosis devices, as these surgeries often require reconnecting intestinal or hollow organ sections. Higher cancer prevalence leads to more surgical procedures, increasing the need for safe and efficient anastomosis devices.
Furthermore, the increasing product development activities maong the key market players are further escalating the market. For instance, in August 2025, SafeHeal®, a leading innovator in colorectal cancer surgery, announced that it had been granted European Union marketing approval for its Colovac® device under the new medical device regulation.
Asia-Pacific Anastomosis Devices Market Trends
The anastomosis devices market in the Asia-Pacific region is being driven by the rising incidence of chronic diseases, including cardiovascular disorders, gastrointestinal conditions, and cancer, which increase the demand for surgical procedures.
According to the National Library of Medicine(2025), the incidence of inflammatory bowel disease (IBD) in Japan was 2,456 cases in 2022, and the forecasted incidence per 100,000 population for ulcerative colitis (UC) and Crohn’s disease (CD) in 2032 was projected to be 33.28 and 5.68 respectively. Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is increasing the demand for anastomosis devices because many patients eventually require surgery when medications are not effective. In severe cases, surgeons need to remove damaged or inflamed parts of the intestine and reconnect the healthy sections, a process that requires anastomosis devices such as staplers and sutures. Therefore, the increasing number of IBD cases is driving higher demand for safe, reliable, and efficient anastomosis devices used in gastrointestinal surgeries. As a result, the demand for Anastomosis devices has surged, driving the growth of the Asia-Pacific market for these devices.
Furthermore, according to the International Agency for Research on Cancer(2025), the estimated number of new colorectal cancer cases in Australia was 18,500 in 2025, and this number was expected to rise to 26,900 by 2045. The rising number of colorectal cancer cases is boosting the anastomosis devices market because many patients need surgery to remove cancerous sections of the colon or rectum. After removing the diseased tissue, surgeons must reconnect the healthy parts of the intestine, a process that relies on anastomosis devices. As more people are diagnosed with colorectal cancer, the demand for these devices increases to ensure safe, precise, and efficient surgical outcomes. Additionally, the demand for safe, precise, and minimally invasive surgical solutions drives wider adoption of advanced anastomosis devices.
Who are the major players in the anastomosis devices market?
The following are the leading companies in the anastomosis devices market. These companies collectively hold the largest market share and dictate industry trends.
The competitive landscape of the anastomosis devices market is shaped by intense innovation, strategic partnerships, regulatory approvals, and product differentiation as companies strive to offer safer, more efficient solutions. Major medical device manufacturers are constantly upgrading their portfolios with advanced staplers, automated systems, and minimally invasive technologies to meet surgeon preferences and reduce complications. In addition, competition is driven by technological advancements such as magnetic compression anastomosis, bio absorbable connectors, and smart devices with integrated feedback, which help improve procedural outcomes. Key players are also engaging in mergers, acquisitions, and collaborations to expand geographic reach and strengthen clinical presence, while regulatory clearances and real world evidence play an important role in gaining market acceptance. Overall, competition encourages continuous product development and broader access to next generation anastomosis devices across hospitals and surgical centers worldwide.
Recent Developmental Activities in the Anastomosis Devices Market
Surgical Sealant
Surgical Adhesive
Others
Reusable
Gastrointestinal Surgery
General Surgery
Others
Ambulatory Surgical Centers
Others
AI-Powered Innovations and Applications:
AI-powered innovations are starting to transform the anastomosis devices market by making surgeries safer, faster, and more precise. Artificial intelligence can assist surgeons in planning and performing complex procedures by analyzing patient data, predicting risks, and guiding optimal device placement. Some AI-enabled systems can monitor tissue alignment, detect potential leaks, and provide real-time feedback during anastomosis, reducing complications. These technologies are especially useful in minimally invasive and robotic-assisted surgeries, where precision is critical. By improving surgical outcomes, shortening operation times, and enhancing overall efficiency, AI-powered applications are driving the adoption of advanced anastomosis devices in hospitals and surgical centers worldwide.
U.S. Tariff Impact Analysis on Anastomosis Devices Market:
Tariffs imposed by the United States on imported medical devices can affect the anastomosis devices market in several ways. When tariffs increase the cost of imported components or finished products, manufacturers may face higher production expenses, which can lead to higher prices for hospitals and healthcare providers. This can slow down the adoption of advanced anastomosis devices, especially in cost sensitive healthcare facilities. In some cases, tariffs may encourage manufacturers to shift production to domestic suppliers or invest more in local manufacturing to avoid extra costs. While this can strengthen U.S. based production in the long term, in the short term higher tariffs can make devices more expensive and limit market growth by reducing demand or delaying technology upgrades in surgical centers.
How This Analysis Helps Clients
1. What is the growth rate of the anastomosis devices market?
- The global anastomosis devices market is expected to increase from 4,159.35 million in 2025 to 6,922.84 million by 2034, reflecting strong and sustained growth.
- The global anastomosis devices market is growing at a CAGR of 5.86% during the forecast period from 2026 to 2034.
- The market of anastomosis devices is being primarily driven by higher demand for surgical procedures due to the expanding burden of chronic illness, increasing adoption of minimally invasive surgical technologies and robotic assisted surgeries, and rising focus on product development initiatives among the key market players.
- The leading companies operating in the anastomosis devices market include B.Braun SE, Intuitive Surgical Operations, Inc., Baxter, Johnson & Johnson Services Inc., Medtronic, Sinolinks Medical Innovation, Inc., Dolphin Sutures, Golden Stapler surgical Co. Ltd., Changzhou Haiers Medical Devices Co., Ltd., Getinge AB, Terumo Corporation, ConMed Corporation, Teleflex Corporation, Dextera Surgical Inc., Peters Surgical, MIZUHO Corporation, CarpoNovum Corporation, Purple Surgical, Seger Surgical Solutions Ltd., Biowin Pharmaceuticals Co., Ltd., and others.
- North America is expected to dominate the overall anastomosis devices market due to its well-established healthcare infrastructure, high surgical procedure volumes, and early adoption of advanced surgical technologies. The region has a strong presence of leading medical device manufacturers and continuous investment in research and product innovation, which accelerates the availability of technologically advanced anastomosis devices. In addition, favorable reimbursement policies, higher healthcare spending, and widespread adoption of minimally invasive and robotic-assisted surgeries support market growth. The rising prevalence of chronic disorders which require surgical resection and reconnection of tissues such as cardiovascular disorders, colorectal cancer, and gastrointestinal conditions further drives the demand for anastomosis devices, while the presence of skilled surgeons and advanced clinical training programs enhances their adoption across hospitals and ambulatory surgical centers. These factors collectively position the region as a leading contributor to the global market.
- In the product segment of the anastomosis devices market, the surgical stapplers category is estimated to account for the largest market share in 2025.
- Higher demand for surgical procedures due to the expanding burden of chronic illnesses: The expanding burden of chronic illnesses such as cardiovascular diseases, gastrointestinal disorders, cancer, and diabetes has led to a higher demand for surgical procedures. Anastomosis devices play a critical role in these surgeries by enabling faster, more precise, and consistent tissue joining compared to traditional suturing methods. As the number of complex and repeat surgeries increases, hospitals and surgeons are increasingly adopting anastomosis devices to reduce operating time, minimize surgical complications, and improve patient outcomes. This growing reliance on surgical interventions for chronic disease management is directly driving the demand for advanced anastomosis devices across healthcare settings.
- Increasing adoption of minimally invasive surgical technologies and robotic assisted surgeries: The growing use of minimally invasive surgical techniques is driving the expansion of the anastomosis devices market by changing how complex surgeries are performed. Procedures like laparoscopic and robotic-assisted surgeries require precise, reliable, and efficient methods for connecting tissues, boosting demand for advanced anastomosis devices over traditional manual suturing. These devices allow surgeons to create secure and consistent connections while reducing operating time, blood loss, and complication risks. Because minimally invasive surgeries also offer benefits such as shorter hospital stays, faster recovery, and less post-operative pain, hospitals and surgical centers are increasingly adopting anastomosis devices to enhance procedural efficiency and patient outcomes, fueling market growth.
- Rising focus on product development initiatives: The rising focus on product development initiatives is significantly contributing to the growth of the anastomosis devices market by driving continuous innovation and improving surgical outcomes. Manufacturers are investing in the development of advanced anastomosis devices that offer better precision, reduced operating time, and lower risk of complications such as leakage or infection. New product designs, including minimally invasive, automated, and bio-compatible anastomosis systems, are making procedures safer and easier for surgeons, which encourages wider adoption in hospitals and surgical centers. Additionally, ongoing product improvements help expand the use of anastomosis devices across different surgical specialties, such as gastrointestinal, cardiovascular, and colorectal surgeries, thereby increasing overall market demand.
This Anastomosis devices market report offers a comprehensive overview of the global Anastomosis devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product (Surgical Staplers {Powered, Manual}, Surgical Sutures, Surgical Sealant, Surgical Adhesives, and Others), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, General Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing anastomosis devices market.
Anastomosis devices are medical instruments designed to surgically connect two hollow structures, such as blood vessels or segments of the intestine. They enable surgeons to create secure and precise connections during procedures including gastrointestinal, cardiovascular, and colorectal surgeries.
The overall anastomosis devices market is being collectively boosted by several converging factors, including the rising volume of surgical procedures and the growing burden of chronic diseases such as cardiovascular disorders, cancer, and gastrointestinal conditions which often require surgical resection and reconnection of tissues. Additionally, increased adoption of minimally invasive and robotic-assisted surgeries are driving demand for advanced anastomosis devices that offer precision and faster recovery. Furthermore, continuous product development and technological advancements are improving device safety, ease of use, and clinical outcomes, encouraging wider adoption among surgeons. Favorable healthcare infrastructure, improved reimbursement in developed regions, and increasing awareness about the benefits of automated and stapling-based anastomosis techniques are further supporting market growth. Together, these factors are accelerating adoption across hospitals, clinics, and ambulatory surgical centers, fueling robust growth in the anastomosis devices market.
Get More Insights into the Report @Anastomosis Devices Market
What are the latest anastomosis devices market dynamics and trends?
The global market for anastomosis devices has witnessed significant growth in recent years, largely driven by increasing demand for surgical procedures due to the expanding burden of chronic illnesses such as cardiovascular diseases and gastrointestinal diseases.
Impact of Cardiovascular Diseases:
According to the National Library of Medicine (2025), the global burden of peripheral artery disease (PAD) is rising sharply, with an estimated 113 million people affected in 2021, a number projected to increase to 189 million by 2030, 273 million by 2040, and 363 million by 2050. PAD is characterized by progressive arterial narrowing and blockage, often in the lower limbs, which frequently necessitates bypass surgeries, endarterectomy, and revascularization procedures when medical therapy or angioplasty is insufficient. These procedures rely heavily on vascular anastomosis devices such as coupling systems, proximal anastomosis devices, and suturing or stapling tools to restore blood flow efficiently and safely.
Impact of Gastrointestinal Diseases
According to the International Agency for Research on Cancer (2025), approximately 2.06 million new cases of colorectal cancer were reported worldwide in 2025, and this number is projected to rise to around 3.29 million by 2045. The growth of colorectal cancer cases is mainly because its treatment often requires surgical intervention. Surgery is a primary approach for managing colorectal cancer and typically involves removing the affected section of the bowel and reconnecting the remaining parts using anastomosis devices such as staplers and sutures.
However, the increasing product development activities auch as approvals, new product launches among the key market players are further escalating the market.For Example, in September 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration had cleared its MagDIâ„¢ System for side-to-side duodeno-ileal (DI) anastomosis, marking a significant milestone in the use of innovative magnetic compression technology for digestive surgery.
However, one of the major challenges in the anastomosis devices market is the risk of anastomotic leakage and other post-operative complications. Anastomotic leakage occurs when the surgical connection between two hollow structures, such as blood vessels or intestinal segments, fails to seal properly, allowing fluids or contents to escape. This can lead to serious complications, including infection, prolonged hospital stays, additional surgeries, and even life-threatening conditions. Because of this risk, surgeons may be cautious in adopting new or advanced anastomosis devices, especially if clinical evidence supporting their safety and reliability is limited. As a result, device manufacturers must focus on improving precision, durability, and safety features to reduce leakage rates, which directly influences the market adoption and growth of anastomosis devices.
Anastomosis Devices Market Segment Analysis
Anastomosis Devices Market by Product (Surgical Staplers {Powered, Manual}, Surgical Sutures, Surgical Sealant, Surgical Adhesives, and Others), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, General Surgery, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Anastomosis Devices Market Regional Analysis
North America Anastomosis Devices Market Trends
North America is expected to account for the highest proportion of 42% of the anastomosis devices market in 2025, out of all regions. North America is expected to dominate the overall anastomosis devices market due to its well-established healthcare infrastructure, high surgical procedure volumes, and early adoption of advanced surgical technologies. The region has a strong presence of leading medical device manufacturers and continuous investment in research and product innovation, which accelerates the availability of technologically advanced anastomosis devices.
According to the Centers for Disease Control and Prevention (2024), approximately 6.5 million people aged 40 years and older in the United States were living with peripheral artery disease (PAD). This high prevalence of PAD significantly boosted the anastomosis devices market, as many patients required vascular interventions such as bypass and revascularization surgeries to restore blood flow. These procedures rely heavily on precise and secure vessel connections, increasing the demand for advanced anastomosis devices that improve surgical efficiency, reduce complications, and support better patient outcomes.
Additionally, according to the Centers for Disease Control and Prevention (2024), the prevalence of inflammatory bowel disease (IBD) in the United States was estimated to be between 2.4 and 3.1 million people, with up to 3.1 million adults affected based on national survey data. This substantial patient population has contributed to the growth of the anastomosis devices market, as a significant number of IBD patients require surgical intervention when medical therapies are no longer effective. Surgical treatment for conditions such as Crohn’s disease and ulcerative colitis often involves removing diseased sections of the intestine and reconnecting healthy bowel segments, a procedure that relies on anastomosis devices. As the incidence of IBD increased, the demand for safe, reliable, and efficient anastomosis devices used in gastrointestinal surgeries also rose, thereby supporting overall market expansion.
However, the increasing product development activities among the key market players are further escalating the market. For instance, in August 2025, Phraxis, Inc., a leader in vascular access innovation, announced the successful completion of the first commercial case using its EndoForceâ„¢ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.
Therefore, the above-mentioned factors are expected to bloster the growth of the anastomosis devices market in North America during the forecast period.
Europe Anastomosis Devices Market Trends
In Europe, the groth of anastomosis devices market is driven by a high prevalence of chronic diseases, and rising demand for complex surgeries. Strong healthcare infrastructure, early adoption of advanced, minimally invasive, and robotic-assisted surgical technologies further drive market growth and adoption across hospitals and surgical centers.
According to the International Agency for Research on Cancer (2025), around 552,000 new colorectum cancer cases were reported in 2025, and this number is expected to rise to approximately 682,000 by 2045.The rising number of cancer cases, especially colorectal and gastrointestinal cancers, is driving demand for anastomosis devices, as these surgeries often require reconnecting intestinal or hollow organ sections. Higher cancer prevalence leads to more surgical procedures, increasing the need for safe and efficient anastomosis devices.
Furthermore, the increasing product development activities maong the key market players are further escalating the market. For instance, in August 2025, SafeHeal®, a leading innovator in colorectal cancer surgery, announced that it had been granted European Union marketing approval for its Colovac® device under the new medical device regulation.
Asia-Pacific Anastomosis Devices Market Trends
The anastomosis devices market in the Asia-Pacific region is being driven by the rising incidence of chronic diseases, including cardiovascular disorders, gastrointestinal conditions, and cancer, which increase the demand for surgical procedures.
According to the National Library of Medicine(2025), the incidence of inflammatory bowel disease (IBD) in Japan was 2,456 cases in 2022, and the forecasted incidence per 100,000 population for ulcerative colitis (UC) and Crohn’s disease (CD) in 2032 was projected to be 33.28 and 5.68 respectively. Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is increasing the demand for anastomosis devices because many patients eventually require surgery when medications are not effective. In severe cases, surgeons need to remove damaged or inflamed parts of the intestine and reconnect the healthy sections, a process that requires anastomosis devices such as staplers and sutures. Therefore, the increasing number of IBD cases is driving higher demand for safe, reliable, and efficient anastomosis devices used in gastrointestinal surgeries. As a result, the demand for Anastomosis devices has surged, driving the growth of the Asia-Pacific market for these devices.
Furthermore, according to the International Agency for Research on Cancer(2025), the estimated number of new colorectal cancer cases in Australia was 18,500 in 2025, and this number was expected to rise to 26,900 by 2045. The rising number of colorectal cancer cases is boosting the anastomosis devices market because many patients need surgery to remove cancerous sections of the colon or rectum. After removing the diseased tissue, surgeons must reconnect the healthy parts of the intestine, a process that relies on anastomosis devices. As more people are diagnosed with colorectal cancer, the demand for these devices increases to ensure safe, precise, and efficient surgical outcomes. Additionally, the demand for safe, precise, and minimally invasive surgical solutions drives wider adoption of advanced anastomosis devices.
Who are the major players in the anastomosis devices market?
The following are the leading companies in the anastomosis devices market. These companies collectively hold the largest market share and dictate industry trends.
- B.Braun SE
- Intuitive Surgical Operations, Inc.
- Baxter
- Johnson & Johnson Services Inc.
- Medtronic
- Sinolinks Medical Innovation, Inc.
- Biowin Pharmaceuticals Co., Ltd.
- Dolphin Sutures
- Golden Stapler Surgical Co., Ltd.
- Changzhou Haiers Medical Devices Co., Ltd.
- Getinge AB
- Terumo Corporation
- ConMed Corporation
- Teleflex Corporation
- Dextera Surgical Inc.
- Peters Surgical
- MIZUHO Corporation
- CarpoNovum AB
- Purple Surgical .
- Seger Surgical Solutions Ltd.
- Others
The competitive landscape of the anastomosis devices market is shaped by intense innovation, strategic partnerships, regulatory approvals, and product differentiation as companies strive to offer safer, more efficient solutions. Major medical device manufacturers are constantly upgrading their portfolios with advanced staplers, automated systems, and minimally invasive technologies to meet surgeon preferences and reduce complications. In addition, competition is driven by technological advancements such as magnetic compression anastomosis, bio absorbable connectors, and smart devices with integrated feedback, which help improve procedural outcomes. Key players are also engaging in mergers, acquisitions, and collaborations to expand geographic reach and strengthen clinical presence, while regulatory clearances and real world evidence play an important role in gaining market acceptance. Overall, competition encourages continuous product development and broader access to next generation anastomosis devices across hospitals and surgical centers worldwide.
Recent Developmental Activities in the Anastomosis Devices Market
- In April 2025, Intuitive, a global leader in minimally invasive care and a pioneer in robotic-assisted surgery, announced that the U.S. Food & Drug Administration (FDA) had cleared its fully wristed SP SureForm 45 stapler for use with the da Vinci SP surgical system in thoracic, colorectal, and urologic procedures.
- In March 2025, GT Metabolic™ Solutions, Inc., a global leader in magnetic surgery, announced that the U.S. Food and Drug Administration (FDA) had cleared a larger, 50mm MagDI™ System magnet to complement the system’s existing 40mm magnet. This expansion allowed surgeons to perform magnet-assisted duodenal-ileal anastomosis on a broader range of patients.
- Anastomosis Devices by Product Exposure
- Powered
- Manual
Surgical Sealant
Surgical Adhesive
Others
- Anastomosis Devices by Usability Exposure
Reusable
- Anastomosis Devices by Application Exposure
Gastrointestinal Surgery
General Surgery
Others
- Anastomosis Devices End-Users Exposure
Ambulatory Surgical Centers
Others
- Anastomosis Devices Geography Exposure
- United States Anastomosis Devices Market
- Canada Anastomosis Devices Market
- Mexico Anastomosis Devices Market
- United Kingdom Anastomosis Devices Market
- Germany Anastomosis Devices Market
- France Anastomosis Devices Market
- Italy Anastomosis Devices Market
- Spain Anastomosis Devices Market
- Rest of Europe Anastomosis Devices Market
- China Anastomosis Devices Market
- Japan Anastomosis Devices Market
- India Anastomosis Devices Market
- Australia Anastomosis Devices Market
- South Korea Anastomosis Devices Market
- Rest of Asia-Pacific Anastomosis Devices Market
- South America Anastomosis Devices Market
- Middle East Anastomosis Devices Market
- Africa Anastomosis Devices Market
AI-Powered Innovations and Applications:
AI-powered innovations are starting to transform the anastomosis devices market by making surgeries safer, faster, and more precise. Artificial intelligence can assist surgeons in planning and performing complex procedures by analyzing patient data, predicting risks, and guiding optimal device placement. Some AI-enabled systems can monitor tissue alignment, detect potential leaks, and provide real-time feedback during anastomosis, reducing complications. These technologies are especially useful in minimally invasive and robotic-assisted surgeries, where precision is critical. By improving surgical outcomes, shortening operation times, and enhancing overall efficiency, AI-powered applications are driving the adoption of advanced anastomosis devices in hospitals and surgical centers worldwide.
U.S. Tariff Impact Analysis on Anastomosis Devices Market:
Tariffs imposed by the United States on imported medical devices can affect the anastomosis devices market in several ways. When tariffs increase the cost of imported components or finished products, manufacturers may face higher production expenses, which can lead to higher prices for hospitals and healthcare providers. This can slow down the adoption of advanced anastomosis devices, especially in cost sensitive healthcare facilities. In some cases, tariffs may encourage manufacturers to shift production to domestic suppliers or invest more in local manufacturing to avoid extra costs. While this can strengthen U.S. based production in the long term, in the short term higher tariffs can make devices more expensive and limit market growth by reducing demand or delaying technology upgrades in surgical centers.
How This Analysis Helps Clients
- Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
- Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
- Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
- Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
- Market size analysis for the current anastomosis devices market size (2025), and market forecast for 8 years (2026 to 2034)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the anastomosis devices market.
- Various opportunities available for the other competitors in the anastomosis devices market space.
- What are the top-performing segments in 2025? How these segments will perform in 2034?
- Which are the top-performing regions and countries in the current anastomosis devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the anastomosis devices market growth in the future?
1. What is the growth rate of the anastomosis devices market?
- The anastomosis devices market is estimated to grow at a CAGR of 5.86% during the forecast period from 2026 to 2034.
- The global anastomosis devices market is expected to increase from 4,159.35 million in 2025 to 6,922.84 million by 2034, reflecting strong and sustained growth.
- North America is expected to account for the highest proportion of the anastomosis devices market in 2025, out of all regions. The region dominates the anastomosis devices market due to its strong healthcare infrastructure, high surgical volumes, and early adoption of advanced technologies. A presence of leading medical device manufacturers, continuous innovation, favorable reimbursement, and rising healthcare spending support growth. Additionally, the increasing prevalence of chronic diseases, along with skilled surgeons and advanced training programs, drives demand and adoption of anastomosis devices across hospitals and surgical centers.
- The overall anastomosis devices market is being collectively boosted by several converging factors, including the rising volume of surgical procedures and the growing burden of chronic diseases such as cardiovascular disorders, cancer, and gastrointestinal conditions. Increased adoption of minimally invasive and robotic-assisted surgeries is driving demand for advanced anastomosis devices that offer precision and faster recovery. In addition, continuous product development and technological advancements are improving device safety, ease of use, and clinical outcomes, encouraging wider adoption among surgeons. Favorable healthcare infrastructure, improved reimbursement in developed regions, and increasing awareness about the benefits of automated and stapling-based anastomosis techniques are further supporting market growth. Together, these factors are accelerating adoption across hospitals, clinics, and ambulatory surgical centers, fueling robust growth in the Anastomosis devices market.
- Some of the key market players operating in the anastomosis devices market include B.Braun SE, Intuitive Surgical Operations, Inc., Baxter, Johnson & Johnson Services Inc., Medtronic, Sinolinks Medical Innovation, Inc., Dolphin Sutures, Golden Stapler surgical Co. Ltd., Changzhou Haiers Medical Devices Co., Ltd., Getinge AB, Terumo Corporation, ConMed Corporation, Teleflex Corporation, Dextera Surgical Inc., Peters Surgical, MIZUHO Corporation, CarpoNovum Corporation, Purple Surgical, Seger Surgical Solutions Ltd., Biowin Pharmaceuticals Co., Ltd., others.
Table of Contents
150 Pages
- 1. Anastomosis Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Anastomosis Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Anastomosis Devices Market Key Factors Analysis
- 3.1 Anastomosis Devices Market Drivers
- 3.1.1 Higher demand for surgical procedures due to the expanding burden of chronic illnesses.
- 3.1.2 Increasing adoption of minimally invasive surgical technologies and robotic assisted technologies
- 3.1.3 Rising focus on product development initiatives
- 3.2 Anastomosis Devices Market Restraints and Challenges
- 3.2.1 Risk of anastomotic leakage and post-operative complications
- 3.2.2 Stringent regulatory approval processes
- 3.3 Anastomosis Devices Market Opportunity
- 3.3.1 Technological advancements in stapling,suturing, and sealing systems
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Anastomosis Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Anastomosis Devices Market Assessment
- 7.1 By Product
- 7.1.1 Surgical Staplers
- 7.1.1.1 Powered
- 7.1.1.2 Manual
- 7.1.2 Surgical Sutures
- 7.1.3 Surgical Sealant
- 7.1.4 Surgical Adhesives
- 7.1.5 Others
- 7.2 By Usability
- 7.2.1 Disposable
- 7.2.2 Reusable
- 7.3 By Application
- 7.3.1 Cardiovascular Surgery
- 7.3.2 Gastrointestinal Surgery
- 7.3.3 General Surgery
- 7.3.4 Others
- 7.4 By End-Users
- 7.4.1 Hospitals & Clinics
- 7.4.2 Ambulatory Surgical Centers
- 7.4.3 Others
- 7.5 By Geography
- 7.5.1 North America
- 7.5.1.1 United States Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.1.2 Canada Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.1.3 Mexico Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2 Europe
- 7.5.2.1 France Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2.2 Germany Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2.3 United Kingdom Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2.4 Italy Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2.5 Spain Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.2.6 Rest of Europe Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3 Asia-Pacific
- 7.5.3.1 China Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3.2 Japan Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3.3 India Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3.4 Australia Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3.5 South Korea Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.3.6 Rest of Asia-Pacific Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.4 Rest of the World (RoW)
- 7.5.4.1 Middle East Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.4.2 Africa Anastomosis Devices Market Size in USD million (2023-2034)
- 7.5.4.3 South America Anastomosis Devices Market Size In USD Million (2023-2034)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Anastomosis Devices Market Company and Product Profiles
- 10.1 B.Braun SE
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Intuitive Surgical Operations, Inc.
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Baxter
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Johnson & Johnson Services Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 Medtronic
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Sinolinks Medical Innovation, Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Biowin Pharmaceuticals Co., Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 Dolphin Sutures
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 Golden Stapler Surgical Co., Ltd.
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 Changzhou Haiers Medical Devices Co., Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Getinge AB
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Terumo Corporation
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 CONMED Corporation
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Teleflex Incorporated
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Dextera Surgical Inc.
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 Advanced Medical Solutions Group
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 MIZUHO Corporation
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 CarpoNovum AB
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 Purple Surgical
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 Seger Surgical Solutions Ltd.
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
